Accessibility Menu
Translational Development Acquisition Corp. logo

Translational Development Acquisition Corp.

(NASDAQ) TDACW

Current Price$1.59
Market CapN/A
Since IPO (2025)+675%
5 YearN/A
1 Year+454%
1 Month+1,193%

Translational Development Acquisition Corp. Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

$6.21M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.87 (Low)

Price

$1.59

Volume

53,482.388

Open

$1.64

Previous Close

$1.55

Daily Range

$1.54 - $1.74

52-Week Range

$0.06 - $2.45

Estimated Earnings Date

N/A

TDACW News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Translational Development Acquisition Corp.

Industry

Capital Markets

Headquarters

New York City, DE 10028, US

TDACW Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

-0%

Return on Assets

3%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

29.69%

Stock Overview

Market Cap

N/A

Shares Outstanding

0

Volume

53.48K

Avg. Volume

71.86K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$944.54K

EBITDA

-$944.54K

Operating Cash Flow

-$608.39K

Capital Expenditure

$0.00

Free Cash Flow

-$608.39K

Cash & ST Invst.

$29.79K

Total Debt

$200.00K

Translational Development Acquisition Corp. Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

2

N/A

Net Income

$1.33M

-10.1%

EBITDA

-$281.16K

+19.1%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

-$475.37K

+92.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$500.00K

-92.0%

Return on Assets

3.39%

N/A

Return on Invested Capital

-0.48%

N/A

Free Cash Flow

-$305.16K

-31.8%

Operating Cash Flow

-$305.16K

-31.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,383.74-0.03%
^DJIDJI
$50,866.78-0.01%
^IXICNASDAQ
$25,709.43-0.04%
BTCBitcoin
$62,143.00+0.03%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$14.38-0.13%
TQQQProShares Trust - ProShares UltraPro Qqq
$73.05-0.14%
KEELKeel Infrastructure
$5.13-0.13%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$43.19+0.14%

Questions About TDACW

What is the current price of Translational Development Acquisition Corp.?

Translational Development Acquisition Corp. is trading at $1.55 per share.

What is the 52-week range for Translational Development Acquisition Corp.?

Over the past 52 weeks, Translational Development Acquisition Corp. has traded between $0.06 and $2.45.

How much debt does Translational Development Acquisition Corp. have?

Translational Development Acquisition Corp. total debt is unavailable.

How much cash does Translational Development Acquisition Corp. have on hand?

Translational Development Acquisition Corp. does not have cash on hand data available.

What is Translational Development Acquisition Corp.’s dividend yield?

Translational Development Acquisition Corp. does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.